Impact of grazoprevir and elbasvir in the treatment of hepatitis C virus-infected patients with chronic kidney disease and end-stage renal disease

Fernando Pedraza, Marco Ladino, David Roth

Research output: Contribution to journalReview article

Fingerprint Dive into the research topics of 'Impact of grazoprevir and elbasvir in the treatment of hepatitis C virus-infected patients with chronic kidney disease and end-stage renal disease'. Together they form a unique fingerprint.